2015 TSAAI Annual Meeting

Chattanooga, TN US
August 15, 2015 to August 16, 2015

The 2015 TSAAI Annual Meeting attracts regional allergy providers for educational and didactic lectures given by nationally known experts in their particular fields of expertise.  Attendees have the opportunity to interact with the speakers and their collegues before and after the lectures.

     

Target Audience

Allergists, Immunologists, Nurses

Learning Objectives

   At the conclusion of this activity, participants should be able to:

  • Initiate appropriate evaluation of PIDD based on the cutaneous findings
  • Join cutaneous findings to specific PIDDs
  • Develop a systematic approach to evaluating patients with multiple antibiotic allergies
  • Identify the tests that are used to measure small airways obstruction
  • Initiate the appropriate therapy for small airways obstruction in asthma
  • Recognize the differences in treatment between COPD and asthma
  • Determine the differences in pathophysiology between COPD and asthma
  • Describe the pathophysiology of Hereditary Angioedema
  • Compare SCIT and SLIT regarding efficacy and adherence in the use of allergic rhinitis and asthma
  • Present current management strategies in life-threatening food allergies
Additional information
Disclosure: 

Disclosure Policy and Disclosures

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

▲J. Andrew Bird, MD  

   Speaker:  Nutricia

   Research Grants:  DBV Technologies, Allergen Research Corporation

▲Thomas Fleisher, MD  

    Employed by National Institutes of Health (NIH)

    No conflicts of interest

▲David Khan, MD  

   Speaker:  AztraZeneca, Genentech, Meda

   Honorarium:  Baxter, Genentech

▲Phillip Lieberman, MD  

    Speaker:  AstraZeneca, Genentech, Meda, Merck, Teva

    Consultant/Advisory Board:  Meda

    Research Grant:  Novartis

▲John Oppenheimer, MD  

    Consultant/Clinical Research:  GlaxoSmithKline, Meda, Mylan

    Associate Editor:  Annals of Allergy, Allergy Watch, Current Allergy and Asthma Reports

    Research Grant:  BD, Novartis, Santi-fi, AstraZeneca

    Board of Directors:  ABAI

▲Mark Riedl, MD

    Consulting, Advisory Board:  BioCryst, CSL Behring, Dyax, Pharming, Salix, Shire

    Speaker:  CSL Behring, Dyax, Salix, Shire

    Research Grants:  BioCryst, CLS Behring, Dyax, Pharming, Shire  

* Karthik Krishnan, MD  

  Clinical Research Principal Investigator: Fujisawa Healthcare, Merck Sharp & Dohme,   Genentech

   Sub-Investigator: AstraZeneca

   Employed by The Allergy, Asthma & Sinus Center

The following have no relevant financial relationships to disclose:

R. Stokes Peebles, MD

    Reba Green - Staff

Education Staff has no relevant financial relationships to disclose.

▲ Speaker

 *  Program Chair and Physician Planner

Course summary
Available credit: 
  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Attendance
Course opens: 
08/14/2015
Course expires: 
08/15/2017
Event starts: 
08/15/2015 - 7:00am
Event ends: 
08/16/2015 - 12:30pm
Cost:
$0.00
Rating: 
0
The Chattanoogan Hotel
1201 Broad Street
Chattanooga, TN 37402
United States

Speakers are nationally known physicians in their respective fields.

Available Credit

  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Attendance

Accreditation Period

Course opens: 
08/14/2015
Course expires: 
08/15/2017

Price

Cost:
$0.00
Please login or create an account to take this course.